Morgan Stanley Call 42.5 OMV 20.1.../ DE000MG5TTW0 /
15/11/2024 18:04:45 | Var.+0.001 | Denaro22:00:36 | Lettera22:00:36 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
0.043EUR | +2.38% | - Quantità in denaro: - |
- Quantità in lettera: - |
OMV AG | 42.50 EUR | 20/12/2024 | Call |
GlobeNewswire
26/03
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
16/01
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
14/09/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center